Drug Discovery
Our Drug Discovery Division includes nationally-recognized laboratories with expertise in both experimental and computional approaches to drug discovery, drug design, and drug responses. Projects include the development of anti-cancer agents, anti-inflammatory drugs, anti-thrombotic drugs, novel opiate analgesics, anti-convulsants, anti-Alzheimer and anti-Parkinson drugs, agents for the treatment of alcohol, tobacco, and psychostimulant abuse, neuroprotective agents, and drugs that interact with nicotinic receptors. Outstanding fundamental research is also underway to understand cell signaling pathways and to develop strategies to correct signaling defects that cause disease.
- Cell Biology
- Chemical Biology
- Computational Chemistry
- Medicinal Chemistry
- Molecular Biology
- Molecular, Cellular, Integrative Pharmacology
- Natural Product Chemistry
- Structure-based Drug Design
Cell Biology
Faculty
Chemical Biology
Faculty
Computational Chemistry
Faculty
Medicinal Chemistry
Faculty
Molecular Biology
Faculty
Molecular, Cellular, Integrative Pharmacology
Faculty
- Val Adams
- Penni Black
- Linda Dwoskin
- Gregory Graf
- Charles Loftin
- Markos Leggas
- Kim Nixon
- Jim Pauly
- Todd Porter
- Hsin-Hsiung Tai
Natural Product Chemistry
Faculty
- Sylvie Garneau-Tsodikova
- Kyung-Bo Kim
- John Littleton
- Todd Porter
- Jurgen Rohr
- Jon Thorson
- Steven Van Lanen
